Stock Region Penny Picks
Stock Region Watchlist Newsletter - Tuesday, July 8, 2025
Stock Region Watchlist Newsletter - Tuesday, July 8, 2025
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: This newsletter is for informational purposes only and should not be considered financial advice. Always do your own research and consult with a financial advisor before making investment decisions. Stocks mentioned here are not endorsements or recommendations.
Hello, Stock Region Family!
Buckle up, because today’s watchlist is packed with exciting updates, groundbreaking achievements, and a few eyebrow-raising moves in the market. Let’s dive in and see what’s making waves today.
1. $SQNS - Sequans’ Bold Bitcoin Bet
Sequans has closed a whopping $384 million strategic investment to launch a Bitcoin Treasury Initiative. Yes, you read that right—Bitcoin! This move is bold, ambitious, and could be a game-changer for the company. But let’s be real, it’s also a high-stakes gamble. With Bitcoin’s volatility, this could either be a genius move or a cautionary tale. Keep an eye on this one—it’s bound to spark some heated debates in the financial world.
2. $PROK - ProKidney’s Promising Trial Results
ProKidney has reported statistically and clinically significant results for its Phase 2 REGEN-007 trial. Their drug, Rilparencel, is showing promise for patients with chronic kidney disease and diabetes. This is the kind of news that gives hope to millions and could position ProKidney as a leader in this space. If you’re into biotech, this is one to watch closely.
3. $NDRA - ENDRA’s Patent Win
ENDRA Life Sciences is set to be granted a U.S. patent for its Radio Frequency Applicator. Patents are like golden tickets in the med-tech world, and this one could open doors for ENDRA. It’s a small but significant step forward.
4. $LSB - LakeShore Biopharma’s $15M Financing
LakeShore Biopharma has announced a $15 million private placement financing. While this isn’t the flashiest news, it’s a solid move to fuel their growth. Financing rounds like these often signal confidence in a company’s future.
5. $BCTX - BriaCell’s Survival Milestone
BriaCell has achieved a remarkable milestone: 52% of patients in their Phase 2 trial for metastatic breast cancer have surpassed the one-year survival mark. This is the kind of news that warms your heart and reminds us why biotech innovation matters. Kudos to BriaCell for making a real difference in patients’ lives.
6. $LRHC - La Rosa Realty’s Strategic Move
La Rosa Realty LLC has entered a strategic agreement with The Agency Dominican Republic, securing exclusive rights for IBIS sales in Puerto Rico. Real estate meets strategy here, and this partnership could open up lucrative opportunities in the Caribbean market.
7. $ZVSA - ZyVersa’s Compassionate Use Approval
ZyVersa Therapeutics is supporting FDA-authorized emergency compassionate use of its Cholesterol Efflux Mediator™ VAR 200 for a patient with ApoCII Amyloidosis. This is a heartwarming example of science stepping up to meet urgent medical needs.
8. $POAI - Predictive Oncology’s $10M Partnership
Predictive Oncology has inked a $10 million share purchase agreement with Yorkville Advisors to advance AI-driven drug discovery. AI and biotech are a match made in heaven, and this partnership could lead to groundbreaking discoveries.
9. $RLYB - Recursion’s Acquisition of REV102
Recursion has acquired full rights to REV102, a potential first-in-class oral ENPP1 inhibitor for hypophosphatasia. This acquisition could position Recursion as a leader in tackling this rare disease.
10. $BTCS - Ethereum Acquisition Buzz
BTCS Inc. saw a staggering 23M volume today after announcing its intent to raise $100 million for a strategic Ethereum acquisition. Using a DeFi/TradFi flywheel, no less! This is a bold move that screams innovation, but it’s also a high-risk play. Will it pay off? Time will tell.
11. $SOBR - European Patent for Alcohol Screening
SOBR Safe has been granted a European patent for its noninvasive transdermal alcohol screening system. This could be a game-changer for industries like transportation and law enforcement. Keep an eye on SOBR as they expand their reach.
12. $SLDB - Solid Biosciences’ Gene Therapy Approval
Solid Biosciences has received FDA IND and Health Canada CTA approval for its first-in-class cardiac gene therapy to treat CPVT. This is a huge step forward for gene therapy and could be a lifesaver for patients with this rare condition.
13. $GROV - HumanCo’s Letter to Grove Collaborative
HumanCo Investments has sent a letter to the board of Grove Collaborative. While the details are sparse, this could signal some big changes ahead for Grove. Activist investors often shake things up, so stay tuned.
Today’s watchlist is a rollercoaster of innovation, ambition, and strategic moves. From biotech breakthroughs to bold bets on Bitcoin and Ethereum, there’s no shortage of excitement. But remember, with great potential comes great risk.
What do you think of today’s watchlist? Any stocks catching your eye? Let us know in the comments or on the forum!
Stay savvy,
The Stock Region Team
Disclaimer: This newsletter is not financial advice. Always do your own research and consult with a professional before making investment decisions.